Wiki Prp inections

[amedrano73]

One of our biller said Medicare now covers for PRP injections if we bill 36514? I did some research and only found that Medicare covers it for non-healing wounds for diabetics. Can someone please advise if what my biller is saying is true?

 

[CodingKing]

NCD 110.14 has not had any changes, Apheresis is a continuous infusion and not an injection

A; General

Apheresis (also known as pheresis or therapeutic pheresis) is a medical procedure utilizing specialized equipment to remove selected blood constituents (plasma, leukocytes, plataelets, or cells) from whole blood. The remainder is retransfused into the person from whom the blood was taken.
For purposes of Medicare coverage, apheresis is defined as an autologous procedure, i.e., blood is taken from the patient, processed, and returned to the patient as part of a continuous procedure (as distinguished from the procedure in which a patient donates blood preoperatively and is transfused with the donated blood at a later date).


B. Indications
Apheresis is covered for the following indications:

• Plasma exchange for acquired myasthenia gravis;
• Leukapheresis in the treatment of leukemia;
• Plasmapheresis in the treatment of primary macroglobulinemia (Waldenstrom);
• Treatment of hyperglobulinemias, including (but not limited to) multiple myelomas, cryoglobulinemia and hyperviscosity syndromes;
• Plasmapheresis or plasma exchange as a last resort treatment of thromobotic thrombocytopenic purpura (TTP);
• Plasmapheresis or plasma exchange in the last resort treatment of life threatening rheumatoid vasculitis;
• Plasma perfusion of charcoal filters for treatment of pruritis of cholestatic liver disease;
• Plasma exchange in the treatment of Goodpasture's Syndrome;
• Plasma exchange in the treatment of glomerulonephritis associated with antiglomerular basement membrane antibodies and advancing renal failure or pulmonary hemorrhage;
• Treatment of chronic relapsing polyneuropathy for patients with severe or life threatening symptoms who have failed to respond to conventional therapy;
• Treatment of life threatening scleroderma and polymyositis when the patient is unresponsive to conventional therapy;
• Treatment of Guillain-Barre Syndrome; and
• Treatment of last resort for life threatening systemic lupus erythematosus (SLE) when conventional therapy has failed to prevent clinical deterioration.

PRP is still:

G0460 for chronic wounds/ulcers
or
0232T - for all other indications.